Overview

Study of Antidepressant Efficacy of a Selective, High Affinity Enkephalinergic Agonist in Anxious Major Depressive Disorder (AMDD)

Status:
Completed

Trial end date:
2011-10-01

Target enrollment:

Participant gender:

Summary

This study will determine if a highly selective enkephalinergic receptor modulator is effective in the treatment of anxious major depressive disorder.

Phase:

Phase 2

Details

Lead Sponsor:

AstraZeneca

Treatments:

Antidepressive Agents